Gemini DRC A Prospective Natural History Study to Evaluate Clinical Characteristics and Disease Progression in Subjects with Non-central Geographic Atrophy (GA) Who Are Carriers of High-risk Genetic Variants of Complement Factor H (CFH)
Research Grant
Administered By
Ophthalmology
Awarded By
Gemini Therapeutics
Start Date
October 10, 2018
End Date
October 18, 2022
Administered By
Ophthalmology
Awarded By
Gemini Therapeutics
Start Date
October 10, 2018
End Date
October 18, 2022